Zobrazeno 1 - 10
of 76
pro vyhledávání: '"John F. Reinus"'
Autor:
Clara Y. Tow MD, John F. Reinus MD
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports, Vol 7 (2019)
In this era of direct-acting antiviral (DAA) therapy for chronic hepatitis C virus (HCV) infection, treated patients have extremely high rates of sustained virologic response to short courses of therapy regardless of stage of fibrosis. Treatment fail
Externí odkaz:
https://doaj.org/article/fd732dbdb1cb48cea5f05c998c14c71f
Autor:
John F. Reinus
Publikováno v:
The American journal of medicine. 135(12)
Autor:
M. Kinkhabwala, Oya M. Andacoglu, Clara Y. Tow, Jack Liu, John F. Reinus, Carlos Figueredo, Kristina R. Chacko, Umut Ozbek
Publikováno v:
Experimental and Clinical Transplantation. 19:439-444
With limited data on the morbidity profile of liver transplant as therapy for alcoholic hepatitis, we compared 30-day and 1-year morbidity in liver transplant recipients with alcoholic hepatitis versus alcoholic cirrhosis.We retrospectively reviewed
Autor:
John F. Reinus, Amit Verma, Noah Kornblum, Yang Shi, Olga Derman, Urvi A Shah, Sengottuvel Viswanathan, Ioannis Mantzaris, Beamon Agarwal, Ira Braunschweig, Murali Janakiram, Aditi Shastri
Publikováno v:
Case Reports in Oncological Medicine, Vol 2018 (2018)
Case Reports in Oncological Medicine
Case Reports in Oncological Medicine
SOS is a rare complication of stem cell transplantation and has significant morbidity and mortality. We present three cases of SOS and highlight underlying risk factors for its development, such as impaired clearance of alkylating agents (especially
Autor:
Yorg Azzi, Enver Akalin, Stuart M. Greenstein, Jeffrey Melvin, Jeffrey M. Weiss, Jay A. Graham, Cindy Pynadath, John F. Reinus, Julia Torabi, Maria Ajaimy, Tia Powell, Juan P. Rocca, Marie Le, Luz E. Liriano, Amy S. Fox, Alesa Campbell, Andrew D. Racine, Jin Carrero, Milan Kinkhabwala, Y. Goldstein
Publikováno v:
Transplant Infectious Disease. 23
Introduction The advent of direct-acting antivirals (DAAs) has created an avenue for transplantation of hepatitis C virus (HCV)-infected donors into uninfected recipients (D+/R-). The donor transmission of HCV is then countered by DAA administration
Autor:
Jay A. Graham, Luz E. Liriano, Stuart M. Greenstein, Milan Kinkhabwala, Cindy Pynadath, John F. Reinus, Y. Goldstein, Yorg Azzi, Juan P. Rocca, Jeffery M. Weiss, Maria Ajaimy, Enver Akalin, Julia Torabi, Tia Powell, Amy S. Fox
Publikováno v:
Clinical Transplantation. 34
The advent of direct-acting antivirals (DAAs) has provided the impetus to transplant kidneys from hepatitis C virus-positive donors into uninfected recipients (D+/R-). Thirty D+/R- patients received DAA treatment. Sustained virologic response (SVR12)
Autor:
Sasa Vukelic, Ulrich P. Jorde, Shivank Madan, Omar Saeed, Daniel J. Goldstein, John F. Reinus, William Jakobleff, S. Forest, Sandhya Murthy, J. Julia Shin, E. Borukhov, Yoram A. Puius, Y. Goldstein, Snehal R. Patel, Daniel B. Sims, Cecilia Nucci
Publikováno v:
The Journal of Heart and Lung Transplantation. 37:1254-1260
BACKGROUND Hepatitis C (HCV) donors are rarely used for cardiac transplantation due to historically poor outcomes. In 2015, nucleic acid testing (NAT) for viral load was added to the routine work-up of organ donors, allowing for the distinction betwe
Autor:
John F. Reinus
Publikováno v:
The American Journal of Medicine. 134:e143-e144
Autor:
John F. Reinus, Kristina R. Chacko
Publikováno v:
Liver Disease ISBN: 9783319985053
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0861b22d6ee68580bf37bccdb2aff35
https://doi.org/10.1007/978-3-319-98506-0_16
https://doi.org/10.1007/978-3-319-98506-0_16
Autor:
Paul J. Gaglio, Manhal Izzy, Ghalib Jibara, John F. Reinus, Aws Aljanabi, Mustafa Alani, Allan W. Wolkoff, Zaid Said, Hina Zaidi, Emily R. Giannattasio
Publikováno v:
Journal of Clinical and Experimental Hepatology. 6:100-108
Background Individuals ineligible for interferon-based hepatitis C therapy may have a worse prognosis than patients who have failed or not received treatment. Aims To provide information about the limitations of medical treatment of hepatitis C in re